Functional Electrical Stimulation for Facial Muscles

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

Partial or complete facial paralysis is the weakness of muscles of facial expression. Facial paralysis causes physical, social and emotional problems. Functional electrical stimulation (FES) for facial paralysis is a technique in which muscles are electrically stimulated, causing them to contract This study is designed to help patients with facial nerve weakness.

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05568108` - Using the Masseteric Nerve for Facial Nerve Reanimation
Completed	`NCT03508440` - Intratympanic Steroid for Bell's Palsy	Phase 2/Phase 3
Completed	`NCT03822728` - Intra-parotid Facial Nerve Imaging in Parotidectomy	N/A

NCT number	NCT04457492
Study type	Interventional
Source	University Health Network, Toronto
Contact
Status	Terminated
Phase	N/A
Start date	November 1, 2021
Completion date	March 16, 2023

Functional Electrical Stimulation for Facial Muscles

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms